Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 8/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9967895 | 0.90 | GRM5 (0.48) | MEN1KMT2AMAOBTSHRMAOA | |
| SCHEMBL8190359 | 0.87 | MAOB (0.53) | MAOBTSHRMAOAALOX5GRIN1 | |
| SCHEMBL8190357 | 0.87 | MAOB (0.53) | MAOBTSHRMAOAALOX5GRIN1 | |
| SCHEMBL3004785 | 0.85 | LMNA (0.55) | MAOBTSHRMAOALMNACYP1A2 | |
| SCHEMBL8483583 | 0.85 | LMNA (0.55) | MAOBTSHRMAOALMNACYP1A2 | |
| SCHEMBL8481310 | 0.85 | LMNA (0.55) | MAOBTSHRMAOALMNACYP1A2 | |
| SCHEMBL11278270 | 0.84 | CTSV (0.44) | MEN1KMT2AMAOBMAOALMNA | |
| SCHEMBL10024632 | 0.80 | TDP1 (0.66) | MEN1KMT2AMAOBTSHRMAOA | |
| SCHEMBL4674930 | 0.80 | MEN1 (0.70) | MEN1KMT2AMAOBMAOAALOX5 | |
| SCHEMBL27081878 | 0.80 | KDM1A (0.49) | MAOBTSHRMAOASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10925840-B2 | Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas | THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-02-23 | — | — | US | disclosed |
| US-20210038540-A1 | METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE (US) | 2021-02-11 | — | — | US | disclosed |
| US-10772849-B2 | Methods of regulating cannabinoid receptor activity-related disorders and diseases | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-09-15 | — | — | US | disclosed |
| US-20200197332-A1 | USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS | THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-06-25 | — | — | US | disclosed |
| US-20200030261-A1 | METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) | 2020-01-30 | — | — | US | disclosed |
| US-20190076379-A1 | METHODS OF TREATING BREAST CANCER | MITCHELL WOODS PHARMACEUTICALS INC (US) | 2019-03-14 | — | — | US | disclosed |
| US-9908841-B2 | Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-03-06 | — | — | US | disclosed |
| US-20180042867-A1 | METHODS OF TREATING CANCER | MITCHELL WOODS PHARMACEUTICALS INC (US) | 2018-02-15 | — | — | US | disclosed |
| US-20170172945-A1 | METHODS OF TREATING BREAST CANCER | MITCHELL WOODS PHARMACEUTICALS INC (US) | 2017-06-22 | — | — | US | disclosed |
| US-20170172944-A1 | METHODS OF TREATING MELANOMA | MITCHELL WOODS PHARMACEUTICALS INC (US) | 2017-06-22 | — | — | US | disclosed |
| US-20170081276-A1 | PREPARATION OF (R,R)-FENOTEROL AND (R,R)- OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV (US) | 2017-03-23 | — | — | US | disclosed |
| US-20100168245-A1 | PREPARATION OF (R,R)-FENOTEROL AND (R,R)-OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2010-07-01 | — | — | US | disclosed |
| US-4853381-A | Ethanolamine compounds | GLAXO GROUP LIMITED (GB) | 1989-08-01 | — | — | US | disclosed |
| EP-0162576-B1 | ETHANOLAMINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 1989-07-26 | — | — | EP | disclosed |
| EP-0162576-A1 | Ethanolamine compounds | GLAXO GROUP LIMITED (GB) | 1985-11-27 | — | — | EP | disclosed |
| US-4011258-A | ETHANOLAMINES | AKTIEBOLAGET DRACO (SW) | 1977-03-08 | — | — | US | disclosed |
| US-3937838-A | BRONCHODILATORS, DIHYDROXYPHENYL ETHANOLAMINES | AKTIEBOLAGET DRACO (SW) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190076379-A1 | METHODS OF TREATING BREAST CANCER | CNR2, ADRB2, CNR1 | MEN1 3975/4885KMT2A 1919/4885MAOB 649/4885 |
| US-20180042867-A1 | METHODS OF TREATING CANCER | GPR55, ADRB2, GRK2 | MEN1 3028/4885KMT2A 1391/4885MAOB 1611/4885 |
| US-20170172945-A1 | METHODS OF TREATING BREAST CANCER | CNR2, ADRB2, CNR1 | MEN1 3975/4885KMT2A 1919/4885MAOB 649/4885 |
| US-20170081276-A1 | PREPARATION OF (R,R)-FENOTEROL AND (R,R)- OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE | ADRB2, ADRB1, ADRB3 | MEN1 4799/4885KMT2A 4127/4885MAOB 1288/4885 |
| US-20210038540-A1 | METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES | CNR1, CNR2, GPR68 | MEN1 2182/4885KMT2A 2950/4885MAOB 1440/4885 |
| US-20170172944-A1 | METHODS OF TREATING MELANOMA | CNR2, ADRB2, CNR1 | MEN1 1723/4885KMT2A 2392/4885MAOB 737/4885 |
| US-20100168245-A1 | PREPARATION OF (R,R)-FENOTEROL AND (R,R)-OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE | ADRB2, ADRB1, ADRB3 | MEN1 4799/4885KMT2A 4127/4885MAOB 1288/4885 |
| US-20200197332-A1 | USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS | ADRB2, ADRB1, ADRA2A | MEN1 1082/4885KMT2A 3251/4885MAOB 1275/4885 |
| US-10772849-B2 | Methods of regulating cannabinoid receptor activity-related disorders and diseases | CNR1, CNR2, GPR68 | MEN1 2182/4885KMT2A 2950/4885MAOB 1440/4885 |
| US-10925840-B2 | Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas | ADRB2, ADRB1, ADRA2A | MEN1 1082/4885KMT2A 3251/4885MAOB 1275/4885 |
| US-20200030261-A1 | METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES | CNR1, CNR2, GPR68 | MEN1 2182/4885KMT2A 2950/4885MAOB 1440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.